Emerald Mutual Fund Advisers Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-832
Closed -$121K 235
2020
Q3
$121K Sell
832
-15
-2% -$2.13K 0.01% 254
2020
Q2
$125K Buy
+847
New +$114K 0.01% 248
2020
Q1
Sell
-1,002
Closed -$115K 224
2019
Q4
$115K Buy
+1,002
New +$99.9K ﹤0.01% 219
2015
Q2
Sell
-3,964
Closed -$415K 256
2015
Q1
$415K Sell
3,964
-162,404
-98% -$16.5M 0.03% 198
2014
Q4
$16.1M Sell
166,368
-45,319
-21% -$4.2M 1.4% 13
2014
Q3
$16.5M Sell
211,687
-10,914
-5% -$704K 1.58% 8
2014
Q2
$14.1M Buy
222,601
+9,640
+5% +$573K 1.29% 16
2014
Q1
$14.3M Sell
212,961
-141,711
-40% -$11M 1.37% 11
2013
Q4
$26.4M Buy
354,672
+124,595
+54% +$7.43M 1.57% 9
2013
Q3
$14.7M Buy
230,077
+15,440
+7% +$770K 2.03% 4
2013
Q2
$6.65M Buy
+214,637
New +$5.71M 1.13% 28

Other funds holding ALNY

Emerald Mutual Fund Advisers Trust's ALNY Position: Q4 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2020, closing a stake of 832 shares — an estimated $121K sold.

Emerald Mutual Fund Advisers Trust first reported a position in ALNY in Q2 2013 and held it in 11 quarters. The position peaked at $26.4M in Q4 2013. 374 funds tracked by Wall St. Rank hold ALNY as of Q4 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Alnylam Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 832 Alnylam Pharmaceuticals shares in Q4 2020, an estimated $121K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Alnylam Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Emerald Mutual Fund Advisers Trust's Alnylam Pharmaceuticals position peaked at $26.4M in Q4 2013.
  • 374 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2020, filed 29 Jan 2021.